Results 121 to 130 of about 301,002 (287)

Hepatitis B vaccination

Indian Pediatrics, 2012
Ningshen Themyaola, A. L. Bairwa
openaire   +3 more sources

Internationally Adopted and Migrant Children Had Important Health Issues Requiring Systematic Initial Screening at Arrival

Acta Paediatrica, EarlyView.
ABSTRACT Aim Internationally adopted and migrant children have similar profiles as they may have experienced many adversities before arrival in their new country. We sought to compare both groups at arrival, focusing on nutritional status, infections and vaccination status.
Céline Lafay, Laurie Miller, Juliette Goutines, Enora Leroux, Albert Faye, Frédéric Sorge   +5 more
wiley   +1 more source

Sensitive detection systems for infectious agents in xenotransplantation*

Xenotransplantation, EarlyView., 2020
Abstract Xenotransplantation of pig cells, tissues, or organs may be associated with transmission of porcine microorganisms, first of all of viruses, to the transplant recipient, potentially inducing a disease (zoonosis). I would like to define detection systems as the complex of sample generation, sample preparation, sample origin, time of sampling ...
Joachim Denner
wiley   +1 more source

The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia

Bulletin of the World Health Organization, 2005
OBJECTIVE: To provide global policy-makers with decision-making information for developing strategies for immunization of infants with a birth dose of hepatitis B vaccine, this paper presents a retrospective cost analysis, conducted in Indonesia, of ...
Carol E. Levin, Carib M. Nelson, Anton Widjaya, Vanda Moniaga, Chairiyah Anwar   +4 more
doaj  

Should We Use Behavioural Predictions in Organ Allocation?

Bioethics, EarlyView.
ABSTRACT Medical predictions, for example, concerning a patient's likelihood of survival, can be used to efficiently allocate scarce resources. Predictions of patient behaviour can also be used—for example, patients on the liver transplant waiting list could receive lower priority based on a high likelihood of non‐adherence to their immunosuppressant ...
Max Drezga‐Kleiminger, Dominic Wilkinson, Thomas Douglas, Joanna Demaree‐Cotton, Julian Koplin, Julian Savulescu   +5 more
wiley   +1 more source

Immunogenicity of Two Doses of Yeast Recombinant Hepatitis B Vaccine in Healthy Older Adults [PDF]

, 1997
Bruce G. Gellin, Richard N. Greenberg, Richard H. Hart, Joseph Bertino, David H. Stein, Maria Deloria Knoll, Mary Lou Clements‐Mann   +6 more
openalex   +1 more source

Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.

Vaccine, 2018
S. Jackson, J. Lentino, James Kopp, Linda Murray, W. Ellison, Margaret Rhee, G. Shockey, L. Akella, Kimberly Erby, W. Heyward, R. Janssen   +10 more
semanticscholar   +1 more source

Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non‐Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group

British Journal of Haematology, EarlyView.
Summary Developing new therapeutic regimens for relapsed/refractory (R/R) B non‐Hodgkin lymphoma (NHL) patients remains a significant unmet clinical need. Our objective was to evaluate atezolizumab (ATE), obinutuzumab (OBI) and venetoclax (VEN) combination in patients with R/R NHL who had received at least one prior anti‐CD20‐containing ...
Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah, Stéphanie Guidez, Olivier Casasnovas, Pierre Feugier, Gandhi Damaj, Hervé Tilly, Loïc Ysebaert, Steven Le Gouill, Nadine Morineau, Emmanuel Gyan, Rémy Gressin, Roch Houot, Morgane Cheminant, Franck Morschhauser, Catherine Thieblemont, Corinne Haioun, Emmanuelle Nicolas‐Virelizier, Luc‐Matthieu Fornecker, Nicolas Daguindau, Guillaume Cartron   +21 more
wiley   +1 more source

A Comprehensive Review of Hepatitis B Vaccine Nonresponse and Associated Risk Factors

Vaccines
Hepatitis B virus (HBV) infection remains a significant global health concern worldwide, contributing to high rates of mortality and morbidity, including chronic hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC).
Albashir Tahir, Sa’adatu Haruna Shinkafi, Ahmed Subeh Alshrari, Abdulmajeed Yunusa, Muhammad Tukur Umar, Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh   +6 more
doaj   +1 more source

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

, 1986
Yoshito Itoh, Emiko Takai, Hiroyuki Ohnuma, K Kitajima, Fumio Tsuda, A Machida, Shunji Mishiro, T. Nakamura, Y. Miyakawa, M Mayumi   +9 more
openalex   +1 more source